伽玛刀放射外科治疗舌咽神经痛:长期随访的安全性与疗效
研究纳入2007至2015年9例难治性舌咽神经痛患者,共行10次伽玛刀放射外科治疗,靶点为颈静脉孔舌咽神经管口,神经受照剂量为80 Gy(3次)或90 Gy(其余)。8例疼痛改善,末次随访6例无痛,未观察到副作用;作者认为伽玛刀安全有效,可作为一线治疗。
要点
- 9例难治性舌咽神经痛患者共接受10次伽玛刀治疗,8例疼痛改善
- 从治疗到症状改善的中位时间为7周(范围2-12个月)
- 末次随访6例无痛(疼痛评分I-III级),其中4例无需服药(I级),未见副作用
核心结论
- 作者认为,基于其安全性和有效性,伽玛刀放射外科似乎是治疗舌咽神经痛的有用工具,包括作为一线治疗。
研究设计与样本
- 2007年至2015年,9例患者(4例男性、5例女性)共接受10次伽玛刀放射外科手术;所有患者均为药物治疗难治性舌咽神经痛,且均有长期疼痛病史。
- 1例患者此前接受过外科微血管减压术;5例在MRI上发现神经血管冲突。
- 在立体定向条件下于MRI和CT上定位舌咽神经,靶点位于颈静脉孔舌咽神经管口;神经受照剂量为80 Gy(3次)或90 Gy(其余)。
- 随访计划为术后3、6、12个月,此后每年一次。
主要发现
- 8例患者疼痛改善,该组从伽玛刀治疗到症状改善的中位时间为7周(范围2-12个月)。
- 首次随访时6例无痛(疼痛强度评分I-III级,基于改编的Barrow神经学研究所三叉神经痛评分系统),其中4例同时无需服药(I级)。
- 1例部分改善(IV级),2例无变化;平均随访46个月(范围10-90个月)。
- 末次随访时6例仍无痛(疼痛评分I-III级),其中4例无痛且无需服药(I级);未观察到副作用。
临床怎么用
- 作者认为伽玛刀放射外科似乎是治疗舌咽神经痛的有用工具,包括作为一线治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Glossopharyngeal neuralgia (GPN) is a rare and disabling condition. Just as for trigeminal neuralgia, Gamma Knife radiosurgery (GKRS) is increasingly proposed as a therapeutic option for GPN. The purpose of this study was to assess long-term safety and efficacy of GKRS for this indication. METHODS From 2007 to 2015, 9 patients (4 male and 5 female) underwent a total of 10 GKRS procedures. All of the patients presented with GPN that was refractory to all medical treatment, and all had a long history of pain. One patient had previously undergone surgical microvascular decompression. In 5 cases, a neurovascular conflict had been identified on MRI. For the GKRS procedure, the glossopharyngeal nerve was localized on MRI and CT under stereotactic conditions. The target was located at the glossopharyngeal meatus of the jugular foramen. The dose administered to the nerve was 80 Gy in 3 procedures and 90 Gy in the others. Follow-up was planned for 3, 6, and 12 months after the procedure and annually thereafter. RESULTS Eight patients experienced an improvement in their pain. The median length of time from GKRS to symptom improvement in this group was 7 weeks (range 2-12 months). At the first follow-up, 6 patients were pain-free (pain intensity scores of I-III, based on an adaptation of the Barrow Neurological Institute scoring system for trigeminal neuralgia), including 4 patients who were also medication-free (I). One patient had partial improvement (IV) and 2 patients had no change. The mean duration of follow-up was 46 months (range 10-90 months). At the last follow-up 6 patients remained pain-free (pain scores of I-III), including 4 patients who were pain free with no medication (I). No side effect was observed. CONCLUSIONS Because of its safety and efficacy, GKRS appears to be a useful tool for treatment of GPN, including first-line treatment.
引用
- Pommier B, Touzet G, Lucas C, et al. Glossopharyngeal neuralgia treated by Gamma Knife radiosurgery: safety and efficacy through long-term follow-up. J Neurosurg. 2017. PMID: 28621622. doi:10.3171/2017.3.JNS162542
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。